Search research articles
Contact Us
Filters
Showing results (91-100 of 96) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 96 results.
Blood
|
November 15, 1996
p21/WAF1 cyclin-kinase inhibitor expression in non-Hodgkin's lymphomas: a potential marker of p53 tumor-suppressor gene function
M Chilosi, C Doglioni, A Magalini, et al.
Leukemia
|
November 4, 2006
ZAP-70 expression, as detected by immunohistochemistry on bone marrow biopsies from early-phase CLL patients, is a strong adverse prognostic factor
R Zanotti, A Ambrosetti, M Lestani, et al.
The American Journal of Pathology
|
September 15, 1998
ALK expression defines a distinct group of T/null lymphomas ("ALK lymphomas") with a wide morphological spectrum
B Falini, B Bigerna, M Fizzotti, et al.
Blood
|
April 9, 1999
ALK+ lymphoma: clinico-pathological findings and outcome
B Falini, S Pileri, P L Zinzani, et al.
Pathologica
|
June 23, 2006
[The Haemolymphopathology Italian Group (H.I.G.): an essential resource for the new technical and organization problems troubling modern haemolymphopathology diagnostics]
M Paulli, T Artusi, C D Baroni, et al.
British Journal of Cancer
|
January 22, 2004
Primary mediastinal large B-cell lymphoma (PMLBCL): long-term results from a retrospective multicentre Italian experience in 138 patients treated with CHOP or MACOP-B/VACOP-B
G Todeschini, S Secchi, E Morra, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 96) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 96 results.
Blood
|
November 15, 1996
p21/WAF1 cyclin-kinase inhibitor expression in non-Hodgkin's lymphomas: a potential marker of p53 tumor-suppressor gene function
M Chilosi, C Doglioni, A Magalini, et al.
Leukemia
|
November 4, 2006
ZAP-70 expression, as detected by immunohistochemistry on bone marrow biopsies from early-phase CLL patients, is a strong adverse prognostic factor
R Zanotti, A Ambrosetti, M Lestani, et al.
The American Journal of Pathology
|
September 15, 1998
ALK expression defines a distinct group of T/null lymphomas ("ALK lymphomas") with a wide morphological spectrum
B Falini, B Bigerna, M Fizzotti, et al.
Blood
|
April 9, 1999
ALK+ lymphoma: clinico-pathological findings and outcome
B Falini, S Pileri, P L Zinzani, et al.
Pathologica
|
June 23, 2006
[The Haemolymphopathology Italian Group (H.I.G.): an essential resource for the new technical and organization problems troubling modern haemolymphopathology diagnostics]
M Paulli, T Artusi, C D Baroni, et al.
British Journal of Cancer
|
January 22, 2004
Primary mediastinal large B-cell lymphoma (PMLBCL): long-term results from a retrospective multicentre Italian experience in 138 patients treated with CHOP or MACOP-B/VACOP-B
G Todeschini, S Secchi, E Morra, et al.
Page
of 10